Clinical Trial Update: Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer [Phase 2]

View source ↗

Summary

This document provides a status update on a Phase 2 trial evaluating intravesical gemcitabine and docetaxel for low-grade, intermediate-risk bladder cancer, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University of Florida | Conditions: Bladder Cancer | Phase 2 | Status: RECRUITING